(Q80242349)

English

Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis

scientific article published on 01 May 2007

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit